Similar Posts
Spain stocks higher at close of trade; IBEX 35 up 0.33% By Investing.com
Investing.com – Spain stocks were higher after the close on Wednesday, as gains in the , and sectors led shares higher. At the close in Madrid, the added 0.33%. The best performers of the session on the were Sacyr SA (BME:), which rose 1.96% or 0.06 points to trade at 3.12 at the close. Meanwhile,…
11 Small-Cap Stocks With Over 15% RoE for 3 Years; 2 Turned Multibaggers in FY26 – 11 Standout Stocks in FY26
A total of 151 small-cap companies maintained RoE above 15% for three straight years till FY25. Of these, 78 stocks posted double-digit gains in FY26. Eleven stood out with 50–100% rallies, led by Lumax Auto and Gabriel India, both turning multibaggers. Source link
SLV ETF: Protect Your Downside Like I Am, With A Collar (NYSEARCA:SLV)
This article was written by Follow I’m Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden Investors Club, a community dedicated to navigating the modern investment climate with humility, discipline, and a non-traditional approach to income investing. I’ve been charting investments since the 1980s, and I spent decades an an…
Guesstimates on November 4, 2025
December S&P E-mini futures: The ES is headed much higher over the coming months. Support is 6400. QQQ: Resistance is 650 and support is 600. TNX (ten year note yield): The 3.75% level is support. A swing up to 5.50% is underway. Euro-US Dollar: The 112 level is support. Upside target at 120 was nearly…
Short Interest in Inv Vk Mun Tr (NYSE:VKQ) Declines By 24.6%
Inv Vk Mun Tr (NYSE:VKQ – Get Free Report) saw a significant decrease in short interest in the month of January. As of January 30th, there was short interest totaling 70,010 shares, a decrease of 24.6% from the January 15th total of 92,818 shares. Approximately 0.1% of the shares of the company are short sold….
Hoth Therapeutics breakthrough! 🧬✨ Why one patient sent Hoth Therapeutics stock forecast soaring by 81% in a single day!
Hoth Therapeutics has recently made headlines with a substantial surge in its stock price, following promising data from the treatment of the first patient using its lead drug candidate, HT-001. This positive development has sparked renewed interest in the Hoth Therapeutics stock. This article Hoth Therapeutics breakthrough! 🧬✨ Why one patient sent Hoth Therapeutics stock…